1. From the Division of Cancer Care and Epidemiology, Department of Oncology and Department of Public Health Sciences, Queen’s University, Kingston, ON, Canada (B.G.); the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston (B.G., A.S.K.); and the Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School...